Straight From The Cutter's Mouth: A Retina Podcast
Straight From The Cutter's Mouth: A Retina Podcast

Straight From The Cutter's Mouth: A Retina Podcast

Jayanth Sridhar

Overview
Episodes

Details

An informal yet insightful commentary featuring interviews and perspectives from leaders in vitreoretinal surgery as well as the next generation of retinal specialists

Recent Episodes

Episode 427: VBS 2024 Annual Meeting Recap with Drs. Finn, Williams, and Yonekawa
APR 24, 2024
Episode 427: VBS 2024 Annual Meeting Recap with Drs. Finn, Williams, and Yonekawa
<p class="" style="white-space:pre-wrap;">Drs. Avni Finn, Basil Williams, and Yoshihiro Yonekawa join to discuss their biggest learning pearls from the 2024 Vit-Buckle Society Annual Meeting.</p><p class="" style="white-space:pre-wrap;"><br></p><p class="" style="white-space:pre-wrap;">Relevant Financial Disclosures: None</p><p class="" style="white-space:pre-wrap;">You can claim CME credits for prior episodes via the AAO website. Visit <a href="https://www.aao.org/browse-multimedia?filter=Audio&amp;sub=ONE.ContentTypes.Audio" target="_blank">https://www.aao.org/browse-multimedia?filter=Audi</a></p>
play-circle
-1 MIN
Episode 426: Journal Club Discussion Including Inflammation Events with Faricimab, DRCR Protocol AC Post Hoc Analysis, Outcomes of Surgery for PDR, AI Interpretation of Images
APR 10, 2024
Episode 426: Journal Club Discussion Including Inflammation Events with Faricimab, DRCR Protocol AC Post Hoc Analysis, Outcomes of Surgery for PDR, AI Interpretation of Images
play-circle
-1 MIN
Episode 425: April 2024 Retinal Physician Preview Including Discussion of Pipeline Targets and Durability Based Agents for Wet Age Related Macular Degeneration and Diabetic Retinopathy
APR 3, 2024
Episode 425: April 2024 Retinal Physician Preview Including Discussion of Pipeline Targets and Durability Based Agents for Wet Age Related Macular Degeneration and Diabetic Retinopathy
<p class="" style="white-space:pre-wrap;">Dr. Marianeli Rodriguez joins to preview the April 2024 edition of Retinal Physician, found online at <a href="http://www.retinalphysician.com/" target="_blank">http://www.retinalphysician.com</a>.</p><p class="" style="white-space:pre-wrap;"><br></p><p class="" style="white-space:pre-wrap;">Relevant Financial Disclosures: Dr. Sridhar has consulted for Genentech and Regeneron.</p><p class="" style="white-space:pre-wrap;">You can claim CME credits for prior episodes via the AAO website. Visit <a href="https://www.aao.org/browse-multimedia?filter=Audio&amp;sub=ONE.ContentTypes.Audio" target="_blank">https://www.aao.org/browse-multimedia?filter=Audi</a></p>
play-circle
-1 MIN
Episode 424: Journal Club Discussion of Diabetic Retinopathy and Quality of Life Measures, Artificial Intelligence and Robotics in Ophthalmology, and Proliferative Sickle Cell Retinopathy Outcomes
MAR 19, 2024
Episode 424: Journal Club Discussion of Diabetic Retinopathy and Quality of Life Measures, Artificial Intelligence and Robotics in Ophthalmology, and Proliferative Sickle Cell Retinopathy Outcomes
<p class="" style="white-space:pre-wrap;">Drs. Avni Finn and Sarwar Zahid join to discuss three recent publications from major ophthalmology journals.</p><p class="" style="white-space:pre-wrap;">Diabetic Retinopathy and Quality of Life (<a href="https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2814583" target="_blank">https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2814583</a>)</p><p class="" style="white-space:pre-wrap;">Artificial Intelligence in Ophthalmology Review (<a href="https://www.ophthalmologyretina.org/article/S2468-6530(24)00044-7/abstract" target="_blank">https://www.ophthalmologyretina.org/article/S2468-6530(24)00044-7/abstract</a>)</p><p class="" style="white-space:pre-wrap;">Proliferative Sickle Cell Retinopathy Surgical Outcomes (<a href="https://www.ophthalmologyretina.org/article/S2468-6530(24)00049-6/abstract" target="_blank">https://www.ophthalmologyretina.org/article/S2468-6530(24)00049-6/abstract</a>)</p><p class="" style="white-space:pre-wrap;"><br></p><p class="" style="white-space:pre-wrap;">Relevant Financial Disclosures: None</p><p class="" style="white-space:pre-wrap;">You can claim CME credits for prior episodes via the AAO website. Visit <a href="https://www.aao.org/browse-multimedia?filter=Audio&amp;sub=ONE.ContentTypes.Audio" target="_blank">https://www.aao.org/browse-multimedia?filter=Audi</a></p>
play-circle
-1 MIN
Episode 423: Angiogenesis 2024 Recap with Dr. Philip Rosenfeld Including Discussion of Imaging for AMD, Geographic Atrophy Treatment Benefits and Risks, and More
MAR 12, 2024
Episode 423: Angiogenesis 2024 Recap with Dr. Philip Rosenfeld Including Discussion of Imaging for AMD, Geographic Atrophy Treatment Benefits and Risks, and More
<p class="" style="white-space:pre-wrap;">Dr. Philip Rosenfeld joins to discuss the Angiogenesis 2024 meeting, with topics covered including imaging breakthroughs for age-related macular degeneration, geographic atrophy treatment benefits and risks, and the importance of molarity in assessing efficacy and safety of intravitreal agents.</p><p class="" style="white-space:pre-wrap;">Relevant Financial Disclosures: Dr. Rosenfeld has consulted for Regeneron and Zeiss. Dr. Sridhar has consulted for Apellis, Genentech, Iveric, and Regeneron.</p><p class="" style="white-space:pre-wrap;">You can claim CME credits for prior episodes via the AAO website. Visit <a href="https://www.aao.org/browse-multimedia?filter=Audio&amp;sub=ONE.ContentTypes.Audio" target="_blank">https://www.aao.org/browse-multimedia?filter=Audi</a></p>
play-circle
-1 MIN